Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
J Infect Dev Ctries ; 6(12): 847-53, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-23276738

ABSTRACT

INTRODUCTION: Tetanus accounts for high morbidity and case fatality rates in developing countries. This study therefore aimed to identify reasons for the persistence of this disease. METHODOLOGY: Paediatric admissions at Ladoke Akintola University Teaching Hospital between 1 January 2006 and 31 December 2008 diagnosed with tetanus were studied. Data was analyzed with SPSS 18 and statistical significance was set at p < 0.05. RESULTS: Of the total 1,681 paediatric admissions, 30 (1.8%) had tetanus. Of the 878 neonatal admissions, 8 (0.9%) had tetanus, while 22 (2.7%) of the total 803 post-neonatal admissions had tetanus. Neonatal tetanus admissions were significantly higher in 2006 compared to 2007 and 2008 (7 [2.3%] versus 1 [0.2%] [χ²= 7.50, P=0.01]). Of the eight mothers whose neonates had tetanus, seven did not receive tetanus toxoids in pregnancy and five (62.5%) were secondary school dropouts. Post-neonatal tetanus cases admitted in the years 2006, 2007, and 2008 were 4, 12, and 6 children respectively. Most of these 22 children did not receive tetanus toxoid immunization in their first year of life. None of the 22 children received booster doses of tetanus toxoids after their first years of life. CONCLUSION: Mothers at risk of their babies having tetanus, such as secondary school dropouts, must be identified antenatally and vaccinated with tetanus toxiod. Their babies should also receive good care post-delivery. Completion of routine tetanus toxoid schedule in the first year and booster doses in the post-neonatal age should be ensured.


Subject(s)
Tetanus/epidemiology , Adolescent , Child , Child, Preschool , Female , Hospitalization/statistics & numerical data , Hospitals, Teaching , Humans , Immunization Schedule , Infant , Infant, Newborn , Male , Nigeria/epidemiology , Pregnancy , Retrospective Studies , Tetanus Toxoid/administration & dosage
2.
J. infect. dev. ctries ; 6(12): 847-853, 2012.
Article in English | AIM (Africa) | ID: biblio-1263621

ABSTRACT

Introduction: Tetanus accounts for high morbidity and case fatality rates in developing countries. This study therefore aimed to identify reasons for the persistence of this disease. Methodology: Paediatric admissions at Ladoke Akintola University Teaching Hospital between 1 January 2006 and 31 December 2008 diagnosed with tetanus were studied. Data was analyzed with SPSS 18 and statistical significance was set at p 0.05. Results: Of the total 1;681 paediatric admissions; 30 (1.8) had tetanus. Of the 878 neonatal admissions; 8 (0.9) had tetanus; while 22 (2.7) of the total 803 post-neonatal admissions had tetanus. Neonatal tetanus admissions were significantly higher in 2006 compared to 2007 and 2008 (7 [2.3] versus 1 [0.2] [?2


Subject(s)
Hospitals , Infant , Infant, Newborn , Patient Admission , Pediatrics , Pregnant Women , Teaching , Tetanus , Tetanus Toxoid
3.
Malar J ; 6: 88, 2007 Jul 06.
Article in English | MEDLINE | ID: mdl-17617910

ABSTRACT

BACKGROUND: Intermittent preventive treatment with sulphadoxine-pyrimethamine (IPT-SP) is currently the recommended regimen for prevention of malaria in pregnancy in endemic areas. This study sets out to evaluate the effectiveness of IPT-SP in the prevention of maternal and placental malaria in parturient mothers in Ibadan, Nigeria, where the risk of malaria is present all year round. METHOD: During a larger study evaluating the epidemiology of congenital malaria, the effect of malaria prophylaxis was examined in 983 parturient mothers. Five hundred and ninety eight mothers (60.8%) received IPT-SP, 214 (21.8%) received pyrimethamine (PYR) and 171 (17.4%) did not take any chemoprophylactic agent (NC). RESULTS: The prevalence of maternal parasitaemia in the IPT-SP, PYR and NC groups was 10.4%, 15.9% and 17% respectively (p = 0.021). The prevalence of placental parasitaemia was 10.5% in the IPT-SP, 16.8% PYR and 17% NC groups, respectively (p = 0.015). The prevalence of maternal anaemia (haematocrit <30%) was 5.7% vs. 8.9% vs. 13.4% among the IPT-SP, PYR and NC groups respectively (p < 0.0001) while that of pre-term delivery (GA <37 weeks) was 10.5%, 19.2% and 25.3% among IPT-SP, PYR and NC groups respectively (p < 0.0001). Babies born to mothers in the IPT-SP, PYR and NC groups had mean birth weights of 3204 +/- 487.16, 3075 +/- 513.24 and 3074 +/- 505.92 respectively (rho < 0.0001). There was a trend towards a lower proportion of low birth weight babies in the IPT-SP group (p = 0.095). CONCLUSION: IPT-SP is effective in preventing maternal and placental malaria as well as improving pregnancy outcomes among parturient women in Ibadan, Nigeria. The implementation of the recently adopted IPT-SP strategy should be pursued with vigour as it holds great promise for reducing the burden of malaria in pregnancy in Nigeria.


Subject(s)
Malaria/prevention & control , Pregnancy Complications, Parasitic/prevention & control , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use , Adolescent , Adult , Antimalarials/administration & dosage , Antimalarials/adverse effects , Antimalarials/therapeutic use , Birth Weight , Dizziness/chemically induced , Drug Combinations , Female , Humans , Malaria/epidemiology , Malaria/parasitology , Male , Nigeria/epidemiology , Parasitemia/epidemiology , Parasitemia/parasitology , Parasitemia/prevention & control , Pregnancy , Prevalence , Pyrimethamine/administration & dosage , Pyrimethamine/adverse effects , Sulfadoxine/administration & dosage , Sulfadoxine/adverse effects , Treatment Outcome
4.
Am J Trop Med Hyg ; 76(1): 1-6, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17255220

ABSTRACT

We compared two dose forms of artemisinin derivatives, dihydroartemisinin suppository (DHA) and intramuscular artemether (ART), in children 6 months to 10 years of age with moderately severe malaria for which oral therapy was not appropriate. Children were randomly allocated to receive three daily doses of DHA or ART followed by a single oral dose of sulfadoxine-pyrimethamine on the third day of both treatment regimens and were monitored for parasitologic and clinical response for 14 days. At enrollment, parasite density was 1,640-523,333/microL (geometric mean parasite density [GMPD] = 58,129/microL) in patients treated with DHA, whereas that for children who received ART was 1,440-559,400/microL (GMPD = 60,387/microL). Mean parasite and fever clearance times were similar in both groups. Days 14 and 28 parasitologic cure rates were 100% (34 of 34) and 96.2% (25 of 26) versus 96.2% (25 of 26) and 91.7% (22 of 24) for children treated with DHA and ART, respectively. In conclusion, both treatment regimens were efficacious and well tolerated.


Subject(s)
Artemisinins/administration & dosage , Artemisinins/therapeutic use , Malaria, Falciparum/drug therapy , Pyrimethamine/therapeutic use , Sesquiterpenes/administration & dosage , Sesquiterpenes/therapeutic use , Sulfadoxine/therapeutic use , Antimalarials/administration & dosage , Antimalarials/therapeutic use , Artemether , Child , Child, Preschool , Drug Combinations , Humans , Infant , Injections, Intramuscular , Malaria, Falciparum/epidemiology , Nigeria/epidemiology , Pyrimethamine/administration & dosage , Sulfadoxine/administration & dosage , Suppositories
5.
J Infect Dev Ctries ; 1(3): 333-6, 2007 Dec 01.
Article in English | MEDLINE | ID: mdl-19734615

ABSTRACT

BACKGROUND: The aim of this prospective study was to determine the prevalence of HCV antibodies among pregnant women and their corresponding offspring in a tertiary medical centre in Southwestern Nigeria. METHOD: Anti-HCV antibodies (anti-HCV antibodies) were analyzed in blood samples from mothers and cord samples from their corresponding offspring using the Enzyme Linked Immunosorbent Assay (ELISA) method. The results obtained from the study were expressed in simple percentages. RESULTS: Out of the 272 consenting pregnant women screened for anti-HCV antibodies, 25 (9.2%) of them were positive. As none of the pregnant women had multiple births, screening the 272 cord sera from their offspring for the same antibodies revealed that 3 (1.10%) of them were also positive. Thus, the prevalence of anti-HCV antibodies in the pregnant women and their offspring were 9.2% and 1.1% respectively. CONCLUSION: If vertical transmission of HCV were to be based on the acquisition of anti-HCV antibodies alone, the prevalence of vertical transmission from HCV infected mothers to offspring in the study was 12.0%. Further studies on vertical transmission are suggested to include analysis for HCV-RNA quantification in pregnant mothers and their offspring as well as a long-term follow-up of neonates seropositive for HCV markers. Such studies are necessary to justify any recommendations to be made for the purpose of reducing HCV infection through vertical transmission.


Subject(s)
Antibodies, Viral/blood , Hepacivirus/immunology , Hepatitis C, Chronic/epidemiology , Hepatitis C, Chronic/transmission , Infectious Disease Transmission, Vertical , Female , Fetal Blood/virology , Hepatitis C, Chronic/immunology , Hospitals, University/statistics & numerical data , Humans , Infant, Newborn , Nigeria/epidemiology , Pregnancy , Prevalence , RNA, Viral/blood , Serologic Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...